REVENUE MEMORANDUM CIRCULAR NO. 57-2022 issued on April 27, 2022 publishes the February 2, 2022 letter from Food and Drug Administration OIC-Director General, Dr. Oscar G. Gutierrez Jr., endorsing updates to the List of VAT-Exempt Medicines under Republic Act No. 11534 (CREATE Act), which now includes certain medicines for hypertension, diabetes and COVID-19.